Assay May Prevent Unnecessary Repeat Prostate Biopsies – Renal and Urology News
Epigenetic assay has a high negative predictive value for prostate cancer.
Related Articles
RaLu Trial: Sequence of Radium Then Lutetium in mCRPC Management – Kambiz Rahbar
Oliver Sartor and Kambiz Rahbar discuss the RaLu study examining the safety and efficacy of sequential radiopharmaceutical treatments in metastatic castration-resistant prostate cancer. The discussion…
Pelvic Muscle Rehabilitation after Radical Prostatectomy – Diane Newman
Diane Newman delivers a presentation on pelvic floor muscle rehabilitation following radical prostatectomy, highlighting the prevalence and impact of post-surgical urinary incontinence. She explained that…
SES AUA 2025: Incidence of New Mental Health Diagnoses in Testicular Cancer Survivors
SES AUA 2025 mental health diagnoses in testicular cancer survivors, mental health disorder, orchiectomy for testicular cancer, Truven Marketscan Commercial Claims and Encounters database.
SES AUA 2025: American Urological Association Annual Census Identifies 39% of Practicing Urologists Utilize Unhealthy Coping Mechanisms for Burnout and Stress
SES AUA 2025, urologic workforce shortage, coping mechanisms for urologists, stress management for urologists.
An Overview of Treatment Strategies in Localized Prostate Cancer: From Active Surveillance to Intensive Therapy – Neal Shore
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Neal…
Medicare Part D Changes Reduce Out-of-Pocket Costs for Prostate Cancer Patients – David Morris
Ruchika Talwar interviews David Morris about changes to Medicare Part D resulting from the Inflation Reduction Act. Dr. Morris discusses how these changes benefit prostate…
Advances and Challenges in High-Risk CSPC: A Multidisciplinary Approach to Patient Management – Paul Sieber
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Paul…
Case-Based Discussion on Navigating the Evolving Landscape of Castrate-Resistant Prostate Cancer Management – Oliver Sartor
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: A.…
Real-World Evidence Informs Clinical Decision-Making in Metastatic Castration-Resistant Prostate Cancer – Alan Bryce
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Alan…
Sexual Dysfunction After Radical Cystectomy – Trinity Bivalacqua
Zachary Klaassen and Trinity Bivalacqua discuss sexual dysfunction following radical cystectomy, highlighting significant disparities in how these issues are addressed between male and female patients.…